Clinical Trial: To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD
Study Status: Completed
Recruit Status: RECRUITING
Condition: Atopic Dermatitis (AD)
Study Type: INTERVENTIONAL
Official Title: A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Clinical Trial to Demonstrate the Superiority of 0.3% and 1% OPA-15406 Ointment Versus Vehicle in Pediatric Subjects With At
Brief Summary:
A multicenter, randomized, double-blind, vehicle-controlled, parallel group trial to demonstrate the superiority of 0.3% and 1% OPA-15406 ointment to vehicle in pediatric subjects with AD.This trial consists of the 0.3% OPA-15406 group, the 1% OPA-15406 group, and the vehicle group.
Read more